Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
Ticker Information
Ticker
BRNSCompany Name
BARINTHUS BIOTHERAPEUTICS PLCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQBARINTHUS BIOTHERAPEUTICS PLC - Price to Earnings Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
BRNS - P/E Historical data
| Date | Market Capitalization | Net Income Common Stock | Price to Earnings |
|---|---|---|---|
| 6/30/2025 | $ 59.04M | $ -69.43M | 0 |
| 3/31/2025 | $ 39.94M | $ -65.23M | 0 |
| 12/31/2024 | $ 40.74M | $ -61.07M | 0 |
| 9/30/2024 | $ 59.62M | $ -57.83M | 0 |
| 6/30/2024 | $ 54.39M | $ -63.78M | 0 |
| 3/31/2024 | $ 91.53M | $ -70.66M | 0 |
| 12/31/2023 | $ 95.36M | $ -73.35M | 0 |
| 9/30/2023 | $ 125.34M | $ -77.24M | 0 |
| 6/30/2023 | $ 84.37M | $ -54.93M | 0 |
| 3/31/2023 | $ 84.03M | $ -15.43M | 0 |
Key Performance Insights, Last 5 Years
- BARINTHUS BIOTHERAPEUTICS PLC's latest trailing twelve months (TTM) P/E stands at 0.
- Over the past 5 years, BARINTHUS BIOTHERAPEUTICS PLC's average P/E has been 12.56.
- The median P/E for BARINTHUS BIOTHERAPEUTICS PLC during this period was 12.56
- BARINTHUS BIOTHERAPEUTICS PLC reached its highest P/E over the past 5 years at 17.44.
- The lowest P/E recorded by BARINTHUS BIOTHERAPEUTICS PLC in the same timeframe 7.68
Similar metrics to P/E:
- Earnings Yield - [Calculation] The Earnings Yield, also known as the inverse of the PE ratio [PE], expresses a company’s earnings [NetIncCmn] as a percentage of [MarketCap].
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
Definition of Price to Earnings
[Calculation] Measures a company’s [MarketCap] in relation to its Net Income [NetIncCmn]. A high P/E ratio indicates that investors anticipate greater future earnings growth compared to companies with a lower P/E.Market Cap / Net Inc. Cmn.
(=) P/E P/E for BARINTHUS BIOTHERAPEUTICS PLC is calculated as follows: Market Cap [ $ 0 ] / Net Inc. Cmn. [ $ -17.71M ]
(=) P/E [ 0 ] BRNS - Price to Earnings, Last 5 years
7.68
Minimum
Sep 30, 2022
17.44
Maximum
Dec 31, 2022
12.56
Average
12.56
Median
P/E Benchmark AnalysisMarket
The chart above depicts the distribution of P/E for companies in the Total Stock Market. The average P/E of the companies is 22.52 with a standard deviation of 13.96.
The following table provides additional summary stats:
P/E in the Market:
| filtered constituents | 2.08K |
|---|---|
| min | 0.13 |
| max | 70.11 |
| average | 22.52 |
| median | 18.89 |
| std | 13.96 |